Subordination Agreement in the Biotechnology Industry
23 Contracts & Agreements
- Advaxis, Inc. (1 contract)
- AgeX Therapeutics, Inc. (1)
- BIOCEPT INC (1)
- NAVIDEA BIOPHARMACEUTICALS, INC. (3)
- Opko Health, Inc. (1)
- Organogenesis Holdings Inc. (1)
- PhaseBio Pharmaceuticals Inc (1)
- Sorrento Therapeutics, Inc. (1)
- Sun BioPharma, Inc. (2)
- U.S. Stem Cell, Inc. (11)
- Subordination Agreement, dated as of August 19, 2024 (Sun BioPharma, Inc., Filed With SEC on November 14, 2024)
- Subordination Agreement, dated as of August 8, 2024 (Sun BioPharma, Inc., Filed With SEC on August 13, 2024)
- Subordination Agreement, dated November 17, 2023, by and among Ayala Pharmaceuticals, Inc., Israel Biotech Fund I, L.P. and Israel Biotech Fund II, L.P., Arkin Bio Ventures L.P.... (Advaxis, Inc., Filed With SEC on November 20, 2023)
- Intercreditor and Subordination Agreement, dated as of July 5, 2023, by and among JMB Capital Partners Lending, LLC and Scilex Holding Company (Sorrento Therapeutics, Inc., Filed With SEC on July 10, 2023)
- Subordination Agreement, dated March 15, 2023, between AgeX Therapeutics, Inc., Serina Therapeutics, Inc. and the other investors signatory thereto (AgeX Therapeutics, Inc., Filed With SEC on March 15, 2023)
- Subordination Agreement, dated as of March 19, 2020, by and among Silicon Valley Bank, WestRiver Innovation Lending Fund VIII, L.P. and SFJ Pharmaceuticals X, Ltd (PhaseBio Pharmaceuticals Inc, Filed With SEC on March 30, 2020)
- Amended and Restated Subordination Agreement dated as of August 6, 2019 by and among Dan Road Associates LLC, 85 Dan Road Associates LLC, 275 Dan Road SPE LLC, 65 Dan Road SPE LLC... (Organogenesis Holdings Inc., Filed With SEC on August 8, 2019)
- SUBORDINATION AGREEMENT (NAVIDEA BIOPHARMACEUTICALS, INC., Filed With SEC on August 11, 2014)
- SUBORDINATION AGREEMENT (NAVIDEA BIOPHARMACEUTICALS, INC., Filed With SEC on March 7, 2014)
- SUBORDINATION AGREEMENT (BIOCEPT INC, Filed With SEC on September 23, 2013)
- SUBORDINATION AGREEMENT (NAVIDEA BIOPHARMACEUTICALS, INC., Filed With SEC on June 28, 2013)
- AMENDED AND RESTATED SUBORDINATION AGREEMENT (U.S. Stem Cell, Inc., Filed With SEC on January 13, 2012)
- AMENDED AND RESTATED SUBORDINATION AGREEMENT (U.S. Stem Cell, Inc., Filed With SEC on November 14, 2011)
- SUBORDINATION AGREEMENT (U.S. Stem Cell, Inc., Filed With SEC on November 14, 2011)
- AMENDED AND RESTATED SUBORDINATION AGREEMENT (U.S. Stem Cell, Inc., Filed With SEC on November 14, 2011)
- AMENDED AND RESTATED SUBORDINATION AGREEMENT (U.S. Stem Cell, Inc., Filed With SEC on November 14, 2011)
- AMENDED AND RESTATED SUBORDINATION AGREEMENT (U.S. Stem Cell, Inc., Filed With SEC on November 14, 2011)
- SUBORDINATION AGREEMENT (U.S. Stem Cell, Inc., Filed With SEC on November 14, 2011)
- SUBORDINATION AGREEMENT (U.S. Stem Cell, Inc., Filed With SEC on June 21, 2011)
- AMENDED AND RESTATED SUBORDINATION AGREEMENT (U.S. Stem Cell, Inc., Filed With SEC on May 25, 2011)
- SUBORDINATION AGREEMENT (U.S. Stem Cell, Inc., Filed With SEC on January 12, 2011)
- SUBORDINATION AGREEMENT (U.S. Stem Cell, Inc., Filed With SEC on August 3, 2009)
- AMENDED AND RESTATED SUBORDINATION AGREEMENT (Opko Health, Inc., Filed With SEC on April 2, 2007)
